Alidad Mireskandari, Ph.D., DiamiR's CEO commented that "applying Machine Learning capabilities to our microRNA platform is a key step towards validation of our diagnostic tests.  We are excited about partnering with JADBio, a leader in Automated Machine Learning in life sciences, to develop sophisticated, proprietary ML based testing algorithms to further our development efforts."

"We are thrilled to be partnering with DiamiR," said JADBio's CEO, Pavlos Charonyktakis, "as we are confident that our state-of-the-art ML platform and services will prove instrumental in DiamiR's efforts to efficiently validate their biomarker panels and develop highly accurate diagnostic tests."